A Prospective, Single-center Investigation of the Impact of Antithrombotic Drugs and Cerebral Microbleeds on Cerebral Outcomes in Patients with Coronary Artery Stents

A Prospective, Single-center Investigation of the Impact of Antithrombotic Drugs and Cerebral Microbleeds on Cerebral Outcomes in Patients with Coronary Artery Stents - Antithrombotic Drugs and Cerebral Microbleeds in Coronary Artery Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014882

Enrollment

535

Registered

2014-08-18

Start date

2014-08-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease treated by percutaneous coronary intervention

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Ischemic heart disease with coronary artery stents 2. Performed Brain magnetic resonance imaging in 1 month around the day when coronary stents were implanted 3. Dual antiplatelet therapy for 1 year 4. Age above 20

Exclusion criteria

Exclusion criteria: 1. Claustrophobia 2. Inadequate to be enrolled

Design outcomes

Primary

Measure	Time frame
Cerebral event including cerebral infarction, cerebral hemorrhage, subdural hematoma, epidural hematoma, subarachnoid hemorrhage and transient ischemic attacks after one year	—

Secondary

Measure	Time frame
After one year, 1. cardiac or non-cardiac death 2. cardiac event including sudden death and coronary revascularizations 3. major bleedings by the ISTH criteria (international Society of Thrombosis and Hemostasis)	—

Countries

Japan

Contacts

Public ContactMasashi Masashi

National Cerebral and Cardiovascular Center Cardiovascular Medicine

fujinom@ncvc.go.jp06-6170-1070

Outcome results